Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 599

1.

Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma.

Ronkainen H, Vaarala MH, Kauppila S, Soini Y, Paavonen TK, Rask J, Hirvikoski P.

Oncol Rep. 2009 Jun;21(6):1519-23.

PMID:
19424632
2.

Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma.

Sichani MM, Yazdi FS, Moghaddam NA, Chehrei A, Kabiri M, Naeimi A, Taheri D.

Saudi J Kidney Dis Transpl. 2010 Jan;21(1):69-74.

3.

p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.

Ljungberg B, Bozoky B, Kovacs G, Stattin P, Farrelly E, Nylander K, Landberg G.

Scand J Urol Nephrol. 2001 Feb;35(1):15-20.

PMID:
11291681
4.

Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.

Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M.

J Urol. 2008 Oct;180(4):1284-9. doi: 10.1016/j.juro.2008.06.036. Epub 2008 Aug 15.

PMID:
18707725
5.

Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.

Ronkainen H, Hirvikoski P, Kauppila S, Vaarala MH.

Oncol Rep. 2011 Jan;25(1):129-33.

PMID:
21109967
6.

Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.

Isbarn H, Patard JJ, Lughezzani G, Rioux-Leclercq N, Crépel M, Cindolo L, de la Taille A, Zini L, Villers A, Shariat SF, Bertini R, Karakiewicz PI.

Urology. 2010 Jun;75(6):1378-84. doi: 10.1016/j.urology.2009.07.1221. Epub 2009 Sep 25.

PMID:
19781745
7.

Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.

Petraki CD, Gregorakis AK, Vaslamatzis MM, Papanastasiou PA, Yousef GM, Levesque MA, Diamandis EP.

Tumour Biol. 2006;27(1):1-7. Epub 2005 Dec 8.

PMID:
16340244
8.

Significance of heat shock protein-27 expression in patients with renal cell carcinoma.

Erkizan O, Kirkali G, Yörükoğlu K, Kirkali Z.

Urology. 2004 Sep;64(3):474-8.

PMID:
15351573
9.

Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma.

Parker A, Cheville JC, Lohse C, Cerhan JR, Blute ML.

J Urol. 2003 Aug;170(2 Pt 1):420-4.

PMID:
12853790
10.

Activation of PI3K is associated with reduced survival in renal cell carcinoma.

Merseburger AS, Hennenlotter J, Kuehs U, Simon P, Kruck S, Koch E, Stenzl A, Kuczyk MA.

Urol Int. 2008;80(4):372-7. doi: 10.1159/000132694. Epub 2008 Jun 27.

PMID:
18587247
11.

Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.

Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

Clin Cancer Res. 2007 Dec 15;13(24):7388-93.

12.

Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.

Phuoc NB, Ehara H, Gotoh T, Nakano M, Yokoi S, Deguchi T, Hirose Y.

Urology. 2007 May;69(5):843-8.

PMID:
17482919
13.

Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.

Minardi D, Lucarini G, Filosa A, Milanese G, Zizzi A, Di Primio R, Montironi R, Muzzonigro G.

Int J Immunopathol Pharmacol. 2008 Apr-Jun;21(2):447-55.

PMID:
18547492
14.

Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma.

Kuroda K, Horiguchi A, Asano T, Ito K, Asakuma J, Sato A, Yoshii H, Hayakawa M, Sumitomo M, Asano T.

Urol Int. 2011;87(4):450-6. doi: 10.1159/000330883. Epub 2011 Nov 10.

PMID:
22076227
15.

Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?

Denzinger S, Otto W, Burger M, Hammerschmied C, Junker K, Hartmann A, Wieland WF, Walter B.

World J Surg Oncol. 2007 Feb 5;5:16.

16.

Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.

Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Bergh A, Ljungberg B.

Eur Urol. 2006 Dec;50(6):1272-7. Epub 2006 Jun 13.

PMID:
16814458
17.
18.

Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma.

Iwamura M, Wu W, Muramoto M, Ohori M, Egawa S, Uchida T, Baba S.

Cancer. 1999 Sep 15;86(6):1028-34.

PMID:
10491530
19.

Prognostic factors and analysis of S100a4 protein in resected pulmonary metastases from renal cell carcinoma.

Bandiera A, Melloni G, Freschi M, Giovanardi M, Carretta A, Borri A, Ciriaco P, Zannini P.

World J Surg. 2009 Jul;33(7):1414-20. doi: 10.1007/s00268-009-0023-5.

PMID:
19365673
20.

Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.

Yoo C, Song C, Hong JH, Kim CS, Ahn H.

J Urol. 2008 Aug;180(2):486-91; discussion 491. doi: 10.1016/j.juro.2008.04.034. Epub 2008 Jun 11.

PMID:
18550101
Items per page

Supplemental Content

Write to the Help Desk